# Final Project Readiness Report: Executive Summary

## Overall Project Status
The Biometric Blood Group Detection project (4-class: A+, B+, AB+, O+) using the Mantra MFS100 fingerprint scanner is prepared for final evaluation. The application has been fully audited to ensure no untested claims are presented to users.

## Current Evidence (Verified Metrics)

| Evaluation Set | N Samples | Model Evaluated | Accuracy | 95% Confidence Interval |
| :--- | :--- | :--- | :--- | :--- |
| **Dataset Random Split** | 415 test images | E2 Champion (DenseNet121 Ensemble) | 86.02% | [82.65%, 88.92%] |
| **Pseudo-Subject Split** | 2,769 training images | Real Model Retraining (E7) | Not done | (Unfeasible on CPU) |
| **Live Validation Set** | 303 scans (101 subjects) | E2 Champion (Frozen) | 27.39% | [22.68%, 32.67%] |

*Note: The proxy metadata artifact classifier achieved 44.58% on a random split, and pseudo-subject grouping reduced the proxy pixel classifier accuracy from 85% to 58.46%, indicating significant dataset leakage in random splits.*

## Remaining Limitations
1. **Subject Independence Unverified:** The original dataset lacks subject IDs. Burst-capture sequences artificially inflate random-split accuracy.
2. **Dataset Artifacts:** Metadata artifacts (intensity, contrast, file size) significantly correlate with blood group labels (p=0.0010), demonstrating non-biological cues in the training data.
3. **Cross-Domain Generalization:** The live system exhibits severe domain shift (different contrast/intensity) compared to the training set, flattening the ensemble confidence distributions.
4. **Origin of 38.10%:** The 38.10% test accuracy figure previously cited was tracked back to a 4-class random permutation baseline or subset metric (898 samples, 38.08%), and does not represent true model performance. The actual random split accuracy is 86.02%.
5. **Clinical Validity:** The system is purely a research prototype and cannot be used for clinical diagnosis. 

## Tests Executed and Results
1. **Model Loading & Config:** `test_integration.py` confirmed that the E2 DenseNet121_Fusion_SupCon model initializes successfully.
2. **3-Scan Consensus Inference:** Validated that passing 3 scans properly computes 4-class probabilities summing to 1.
3. **Test Suite Recovery:** 32 failing tests were audited. Outdated API usages were fixed.

## Exact Commands to Launch the Project
1. Open a terminal in the project root directory.
2. Ensure the virtual environment is activated.
3. Start the application: `python app.py`

## Conclusion
The live system does not demonstrate reliable cross-domain four-class blood group classification. Clinical validity is not claimed.
